Stemline Therapeutics Inc (NASDAQ:STML)

Delayed Data
As of Apr 20
 +0.10 / +0.58%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 34.50, with a high estimate of 41.00 and a low estimate of 19.00. The median estimate represents a +99.42% increase from the last price of 17.30.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 37.63%
Growthannually 0.26%


Growthquarterly -16.67%
Growthannually 1,338.43%
Key to the earnings and sales forecast charts.